Abstract
We studied occurrence, disease course, and prognosis of community-acquired bacterial meningitis in HIV-infected adults in the Netherlands. We performed a nationwide, prospective cohort study. Patients over 16 years old with bacterial meningitis were included. Data on patient history, symptoms and signs on admission, laboratory findings, radiologic examination, treatment, and outcome were collected prospectively. For HIV-positive patients additional information was collected retrospectively. From March 2006 to December 2013, 1354 episodes of community-acquired meningitis were included in the cohort. Thirteen patients were HIV-infected (1.0%). The annual incidence of bacterial meningitis was 8.3-fold higher (95%CI 4.6-15.1, P < 0.001) among HIV-infected patients as compared to the general population (10.79 [95%CI 5.97-19.48] vs 1.29 [95%CI 1.22-1.37] per 100.000 patients per year). Predisposing factors (other than HIV), clinical symptoms and signs, ancillary investigations, causative organisms and outcome were comparable between HIV-infected and patients without HIV infection. HIV-infected patients in the Netherlands have a 8.3-fold higher risk for bacterial meningitis as compared to the general population despite cART therapy. C...Continue Reading
References
Nov 17, 1989·JAMA : the Journal of the American Medical Association·A SpanosD T Durack
Sep 1, 1996·Pediatric Pulmonology·R U SorensenL E Leiva
Jul 24, 1998·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·B AlmiranteA Pahissa
Mar 23, 2002·The Journal of Antimicrobial Chemotherapy·Diederik van de BeekJacob Dankert
Oct 29, 2004·The New England Journal of Medicine·Diederik van de BeekMarinus Vermeulen
Jan 24, 2006·Lancet Neurology·Martijn WeisfeltJan de Gans
Dec 14, 2007·The New England Journal of Medicine·Thi Hoang Mai NguyenJeremy J Farrar
Nov 28, 2008·The Lancet Infectious Diseases·Matthijs C BrouwerDiederik van de Beek
Jun 11, 2009·Journal of Acquired Immune Deficiency Syndromes : JAIDS·Pere DomingoUNKNOWN VACH Cohort Study Group
Feb 9, 2010·Lancet Neurology·Diederik van de BeekA H Zwinderman
Feb 18, 2010·PloS One·Martijn WeisfeltDiederik van de Beek
Mar 5, 2010·The New England Journal of Medicine·Neil FrenchCharles F Gilks
Jul 9, 2010·Clinical Microbiology Reviews·Matthijs C BrouwerDiederik van de Beek
Sep 18, 2010·Journal of Neurology·Ravindra Kumar Garg, Manish Kumar Sinha
Oct 1, 2010·Neurology·M C BrouwerD van de Beek
Nov 10, 2010·HIV Medicine·R H PedersenO S Søgaard
Dec 19, 2012·Intensive Care Medicine·Marjolein J LucasDiederik van de Beek
May 1, 2013·Mayo Clinic Proceedings·Kirsten S AdrianiDiederik van de Beek
May 21, 2013·Vaccine·Yeh-Li HoMarta Heloisa Lopes
Mar 4, 2014·Sexually Transmitted Infections·F van AarI V F van den Broek
May 30, 2014·Clinical Epidemiology·Derek J Sloan, Victoria Parris
Citations
Sep 11, 2016·Journal of Neuroimmune Pharmacology : the Official Journal of the Society on NeuroImmune Pharmacology·Kiril E B van VeenDiederik van de Beek
Feb 9, 2017·Current Opinion in Critical Care·Romain SonnevilleGeert Meyfroidt
Mar 18, 2017·Infectious Diseases·Lene Fogt Lundbo, Thomas Benfield
Dec 6, 2017·Asian Pacific Journal of Tropical Medicine·Rodrigo Siqueira BatistaMauro Geller
Feb 13, 2018·AIDS Patient Care and STDs·Karen J VigilRodrigo Hasbun
Nov 4, 2016·Nature Reviews. Disease Primers·Diederik van de BeekEelco Wijdicks
Sep 11, 2019·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·Joseph AgossouMartin Antonio
Nov 27, 2019·Transactions of the Royal Society of Tropical Medicine and Hygiene·Ekram W Abd El-WahabMohammed Metwally
Nov 1, 2018·PloS One·Laure-Amélie de MonteynardUNKNOWN FHDH-ANRS CO4
Feb 6, 2020·Intensive Care Medicine·François BarbierÉlie Azoulay
Mar 18, 2021·ENeurologicalSci·Gavin A SteadJoseph Donovan